In this podcast episode, Amy Oxentenko, MD, discusses her initiatives as ACG president, addressing workforce challenges in the GI space and more.

• Intro :50
• Amy Oxentenko, MD 1:09
• How does it feel to be finishing your year as ACG president? 1:54
• What were your main initiatives and goals for this year, and how did they go? 3:28
• Is there a teaser you can give us for what you will reveal at the ACG annual meeting? 8:39
• Chey and Oxentenko on the critical role of additional research within the future of gastroenterology. 12:01
• What research has the college conducted to better understand the true clinical FTE available to patients? […] Are there certain solutions that have stood out to you in your work? 13:19
• Will there be a task force to comment on the rise of clinicians choosing to participate in more of a locum tenens practice? 18:35
• Can you speak about the recent progress made toward addressing the gender gap in GI? 21:32
• What can listeners do in this political climate to continue to make strides towards equity in the field? 25:47
• What have you learned about yourself in the past year as ACG president? 30:09
• What are you optimistic about in GI after this year? 33:19
• On the other hand, what are you most concerned about for gastroenterology? 36:17
• Any advice for the next ACG president? 39:31
• What is next for you? 41:18
• Thank you, Amy 43:10
• Thanks for listening 43:52

Amy Oxentenko, MD, FACP, FACG, AGAF, is a professor of medicine and vice dean of Mayo Clinic Practice. She is a member of the ACG board of trustees and executive team, serving as ACG president from October 2024-October 2025.

We’d love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc. For more from Dr. Oxentenko, follow @AmyOxentenkoMD on X.

Disclosures: Chey, Berry and Oxentenko report no relevant financial disclosures.

In this special crossover podcast episode, Tuesday Night IBS hosts Jeffrey Roberts, MSEd, BSc, Erica Dermer and Kate Scarlata, MPH, RDN, are joined live by William Chey, MD, and Amanda Lynett, MS, RDN, at FOOD the Main Course Conference in Ann Arbor, MI.

• Intro :02
• About Scarlata :30
• About Chey 1:07
• About Lynett 1:49
• Chey, what are your goals for this year’s FOOD the Main Course Conference? 2:58
• How do you feel that mechanisms of diet are affecting microbiomes? 5:37
• Amanda, what have you learned over the years as you have put together this conference, and how do you think this experience has shaped a more well-rounded program for clinicians? 8:23
• What are you personally going to take away from the conference this year? 11:17
• A discussion on peer-to-peer interactions, the spirit of collaborative care, and what each provider is bringing to the table. 12:22
• Kate, tell us about why you come back to this conference every year. 17:32
• What challenges did you overcome to move the needle forward in diet and GI conditions? 19:14
• Chey, can you talk about the correlation between stress and diet when it comes to IBS? 24:21
• How are we dealing with the ramifications of GLP-1s? 29:33
• As providers, what is your first instinct when patients tell you they started GLP-1s? 32:28
• How is the community going to help listeners weed through Internet noise to find accurate information? 35:01
• Group discussion on the rise of severe constipation. 41:31
• Who decides to send patients for colectomy consultations? 43:33
• Is there anything else you want to share or highlight from the conference? 47:25
• Thank you all 48:58
• Thanks for listening 49:42

Erica Dermer is an IBS and Celiac Disease patient who hosts the Celiac and the Beast blog and You Had Me at Eat podcast series.

Amanda Lynett MS, RDN, is a registered dietitian with her masters. Amanda is with the Division of Gastroenterology at Michigan Medical in Ann Arbor.

Jeffrey Roberts, MSEd, BSc, is a patient advocate and creator of the first website for IBS sufferers. He is the co-founder of Tuesday Night IBS.

Kate Scarlata, MPH, RDN, is a US-based dietitian with over 30 years of experience. Kate’s expertise is in gastrointestinal disorders and food intolerance.

We’d love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc. For more Tuesday Night IBS, be sure check out TuesdayNightIBS.com and to follow and subscribe to their podcast.

Disclosures: Chey and Roberts report no relevant financial disclosures. Scarlata reports stock options with Epicured LLC and FODY Food Company, financial support from Dr. Schar, Mahana Therapeutics, Nestle Health Science, Olipop, Pendulum, QOL Medical.

In this podcast episode, Miguel Regueiro, MD, discusses developing the medical home model for patients with IBD, technological advances for patients in GI and more.

• Intro :58
• The interview/about Regueiro 1:03
• Tell us about your family and where you grew up. 1:24
• How did you get interested in medicine? 2:16
• Who were your early influences? 4:18
• What is the medical home? 5:57
• How did you develop the idea to apply the medical home model to IBD? 7:45
• Did you get any funding from the payers for this model to keep costs under control for this patient population? 10:57
• Why hasn’t this model become standard of care for patients with complex IBD? 14:13
• What has worked, and what hasn’t worked when it comes to adopting an integrative care medical home model? 18:15
• Are there themes patients share as to why they wouldn’t want to be enrolled in a medical home? 21:28
• What motivated your change to go from UPMC to become the GI Chief of Cleveland Clinic? 23:09
• What have you learned in this position at Cleveland Clinic? 25:23
• Are you spending a lot of time on the business side of care as opposed to the patient side? 26:34
• How would you recommend that people prepare for having a position like this? 27:34
• Are you seeing a shift in excitement over taking on leadership roles outside of traditional academics? 30:02
• With our clinical tool chest changing so rapidly, is there a common theme that you use to guide the strategy of the institute on what to invest in? 35:06
• What are the challenges that you still see in the ways we are using telehealth? 39:05
• What are some of the most exciting things you see on the horizon in the realm of IBD management? 40:26
• Thank you, Miguel 42:55
• Thanks for listening 45:11

Miguel Regueiro, MD, is the chief of the Digestive Disease Institute at Cleveland Clinic, and professor in the department of medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.

We’d love to hear from you! Send your comments/questions to guttalkpodcast@healio.com. Follow us on X @HealioGastro @sameerkberry @umfoodoc. For more from Regueiro, follow @MRegueiroMD on X.

Disclosures: Berry and Chey report no relevant financial disclosures. Regueiro reports being on the advisory boards of and consulting for Abavax, Abbvie, Amgen, Biocon, BMS, Boehringer Ingelheim Pharmaceuticals Inc. (BIPI), Celgene, Celltrion, Gilead, Genentech, Johnson and Johnson, Lilly, Merck, Organon, Pfizer, Prometheus, Roche, Salix, Sanofi, Takeda and UBC.